Comment from 60 Degrees Pharmaceuticals, Inc.

Summary: 60 Degrees Pharmaceuticals, Inc. supports the FDA's drug repurposing initiative and proposes tafenoquine as a candidate for treating babesiosis in immunocompromised patients. They advocate for a "totality-of-evidence" framework that allows for the repurposing of drugs for uncommon infectious diseases where large-scale traditional clinical trials are not feasible.